The people's Daily has a voice on the issue of traditional Chinese Medicine

On December 5, the people's Daily published an article entitled "inheritance, innovation and development of traditional Chinese medicine", once again focusing on the development of traditional Chinese medicine The article mentioned that "the essence of traditional Chinese medicine is culture, the thinking of traditional Chinese medicine is philosophy, and the clinical practice of traditional Chinese medicine is technology We should not only inherit the theory of thought, but also the methods of technology At the same time, in the development process of traditional Chinese medicine, we should carry forward the spirit of traditional Chinese medicine, which is sincere and benevolent, so that the Qi Huang gene can be passed on from generation to generation, and this national treasure can make new contributions to building a healthy China and improving people's health and well-being " When it comes to the inheritance of traditional Chinese medicine, we all think of doctors At the same time, we can also think of limiting the development of traditional Chinese medicine by western medicine that does not meet the requirements ▍ the number of traditional Chinese medicine is not dominant According to the survey data of the strategic research group of traditional Chinese medicine of China Institute of science and technology information, 800000 people of traditional Chinese medicine were in China in the early years of the Republic of China According to the 2018 statistical bulletin of China's health development issued by the national health and Health Commission on May 22 this year, there are 3.677 million practicing (Assistant) doctors nationwide, and only 575000 practicing (Assistant) doctors of traditional Chinese medicine, accounting for 15.9% of the whole group The number of doctors is on the rise, but the number of traditional Chinese medicine is in contrast Once there was a professor from a University of traditional Chinese medicine who said that it would take five or eight years for students majoring in traditional Chinese medicine to have education If they went to the doctor's degree again, that would be eleven years Although it took so much time, a considerable number of people do not have a basic belief in traditional Chinese medicine, that is to say, quite a number of undergraduate, master's and doctor's graduates have not yet entered the door of traditional Chinese medicine On July 1 this year, the national health and Health Commission and the State Administration of traditional Chinese medicine jointly issued the notice on the first batch of national key monitoring list of rational drugs (chemical drugs and biological products), which limits the rational use of Chinese patent medicine, and specifies that western medicine must be studied and examined before it can be prescribed, After the implementation of this regulation, it means that many Western doctors who have not received systematic training in traditional Chinese medicine will not be able to prescribe proprietary Chinese medicine for the time being From the current data, the number of doctors who can prescribe Chinese patent medicine will be greatly reduced in the future ▍ in the near future, when Chinese medicine enterprises are under pressure, everyone is very concerned about the topic that western medicine cannot open Chinese medicine In fact, traditional Chinese medicine enterprises bear more pressure and challenge than this regulation It can be said that the influence is much greater than that of Western medicine Saibelan learned at a meeting of Chongqing pharmaceutical fair today that there are more than 1000 varieties of Chinese patent medicine that can enter the hospital at present, and 200-300 kinds are commonly used With the strict supervision of the relevant departments of the state on the rational use of drugs in the hospital, a batch of traditional Chinese medicine will be cleaned in the future At present, for many Chinese patent medicines and traditional Chinese medicine injections, they occupy a considerable share of the medical insurance In order to vacate the cage and change the birds, the National Medical Insurance Bureau will definitely do something for those expensive and ineffective traditional Chinese medicines In addition, the next national drug regulatory authorities will also standardize and even carry out re evaluation of traditional Chinese medicine for those Chinese patent medicines that are not perfect in evidence-based medicine, clinical data, instructions, taboos, etc A participant thought that many current medical policies are not only for chemical drugs, but for all kinds of drugs For example, at present, the consistency evaluation and quantity purchase of chemical drugs are in full swing Will it only be good for traditional Chinese medicine in the future? For traditional Chinese medicine, in addition to being good, there are also many challenges in the future ▍ recently, the list of drugs for 2019 national medical insurance negotiation access was officially released, and the price reduction became the focus of the industry again In this round of national health insurance negotiations, a total of 18 Chinese patent medicines were shortlisted, plus 5 varieties of successfully renewed medical insurance catalogue in 2017, 23 Chinese patent medicines have entered the 2019 version of medical insurance catalogue According to the medical magic cube data, the average decline of 23 Chinese patent medicines in the medical insurance negotiation reached 56.85% Among them, the price of five varieties has dropped by more than 80%, which is surprising Western medicine that does not meet the requirements cannot prescribe traditional Chinese medicine In a short time, traditional Chinese medicine may feel limited, but in the long run, it is certainly good for traditional Chinese medicine Because, professional doctors prescribe professional prescriptions, which will be more beneficial to patients, hospitals and even the whole industry After the negotiation of national medical insurance, the sharp price reduction of Chinese patent medicine also brings us a signal that the State encourages the inheritance and development of traditional Chinese medicine, which is to return to the effectiveness, safety and clinical use value of the medicine in the future on the premise of the value of drug treatment